Iradimed CorpIRMD
What Iradimed Corp does.
IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them. We were originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and we merged our Oklahoma corporation into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014.
We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures and operates dependably in magnetic fields up to 15,000 gauss. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium 3870 MRI Compatible IV Infusion Pump System, introduced in 2025, has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, touch screen user interface, and other special features to safely and predictably deliver anesthesia and other critical care IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated to remain immobile during an MRI scan.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $31.7M | $41.8M | $53.3M | $65.6M | $73.2M | $83.8M |
| Net income | $1.4M | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M |
| Free cash flow | $5.4M | $10.8M | $9.2M | $6.0M | $17.6M | $17.2M |
More on IRMD.
- Iradimed Corp summary
- Iradimed Corp financial statements
- Iradimed Corp key metrics
- Iradimed Corp health scores and style box
- Iradimed Corp earnings
- Iradimed Corp dividends
- Iradimed Corp valuation
- Iradimed Corp ownership and insiders
- Iradimed Corp peers
Figures from Iradimed Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.